Astrana Health, Inc. last reported quarterly results on Nov 5, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $1.0 billion (+7.1% year over year) and diluted EPS of $0.26. It usually reports 36–61 days after a quarter ends. Based on that pattern, the next release is estimated for around Mar 1, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Monday. Based on last year's release for the same quarter on Mar 2, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 36–61 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Nov 5, 2026
36 days after quarter end
From press release
|
Q3 FY2026
ended Sep 30, 2026
|
1,024
+7.1%
|
13
+3372.4%
|
0.26
+2500.0%
|
|
Aug 6, 2026
37 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
973
+48.5%
|
20
+109.5%
|
0.40
+110.5%
|
|
May 7, 2026
37 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
—
|
—
|
—
|
|
Mar 2, 2026
61 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
951
+42.9%
|
6
+186.3%
|
0.12
+183.6%
|
|
Nov 6, 2025
37 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
956
+99.7%
|
0
-97.7%
|
0.01
-97.0%
|
|
Jul 2, 2025
2 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
655
+34.7%
|
9
-50.8%
|
0.19
-52.5%
|
|
May 8, 2025
38 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
620
+53.4%
|
7
-54.9%
|
0.14
-54.8%
|
|
Feb 27, 2025
58 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
665
+88.4%
|
-7
-156.3%
|
-0.14
-155.2%
|
Company profile
- Industry
- Services-Management Consulting Services (SIC 8742)
- Listed as
- ASTH (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Alhambra, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1083446
- Former names
- Apollo Medical Holdings, Inc. (until Feb 13, 2024); SICLONE INDUSTRIES INC (until Jul 15, 2008)
Other Services-Management Consulting Services companies
- Cgi Inc GIB
- Booz Allen Hamilton Holding Corp BAH
- Genpact LTD G
- Fti Consulting, Inc FCN
- Exponent Inc EXPO
- Huron Consulting Group Inc. HURN
- ICF International, Inc. ICFI
- Bowman Consulting Group Ltd. BWMN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.